The U.S. Department of Health and Human Services (HHS) has said it would make available an additional 144,000 doses of the Jynneos vaccine doses available to states and jurisdictions. Bavarian Nordic A/S (OMX:BAVA) is the manufacturer of the vaccine. Jynneos won FDA approval for both smallpox and monkeypox in 2019. There have been approximately 700…
Moderna to build mRNA plant in Africa
As the pendulum of vaccinating the world against COVID-19 begins to swing to developing countries, Moderna (NSDQ:MRNA) will build an mRNA facility in Africa that could produce as many as 500 million 50-µg vaccine doses annually. Its currently authorized booster has a 100-µg dose of mRNA, but the company aims to use a 50-µg dose…
Which companies will likely produce the most COVID-19 vaccine in 2021?
Since the beginning of the pandemic, much of society has pinned its hopes on the availability of a vaccine. Now that several are available across the world, there is hope, said Dr. Anthony Fauci, chief medical advisor to President Joe Biden, in a recent JAMA interview. “There’s light at the end of the tunnel.” One thing that…
Sanofi, GSK offer 20M COVID-19 vaccine doses to COVAX alliance
Sanofi (NSDQ:SNY) and GSK (LON: GSK), which have teamed up to produce a COVID-19 vaccine candidate, have signaled their intent to work with the legal administrator of the COVAX Facility. The two companies have vowed to produce 200 million doses of a vaccine based on the protein subunit AS03 adjuvant. Governments, businesses and health organizations…